These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 945347)

  • 1. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
    Martin WR; Eades CG; Thompson JA; Huppler RE; Gilbert PE
    J Pharmacol Exp Ther; 1976 Jun; 197(3):517-32. PubMed ID: 945347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog.
    Gilbert PE; Martin WR
    J Pharmacol Exp Ther; 1976 Jul; 198(1):66-82. PubMed ID: 945350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo.
    Kumor KM; Haertzen CA; Johnson RE; Kocher T; Jasinski D
    J Pharmacol Exp Ther; 1986 Sep; 238(3):960-8. PubMed ID: 3018228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigma effects of nalorphine in the chronic spinal dog.
    Gilbert PE; Martin WR
    Drug Alcohol Depend; 1976 Oct; 1(6):373-6. PubMed ID: 189982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic actions of ketocyclazocine enantiomers in the dog: absence of sigma- or phencyclidine-like activity.
    Vaupel DB; Cone EJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):211-21. PubMed ID: 1846414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitussive effect of the optical isomers of mu, kappa and sigma opiate agonists/antagonists in the cat.
    Chau TT; Carter FE; Harris LS
    J Pharmacol Exp Ther; 1983 Jul; 226(1):108-13. PubMed ID: 6864534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
    Moerschbaecher JM; Thompson DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):738-48. PubMed ID: 6887010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.
    Harris RA
    J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE; Holtzman SG
    J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.
    Teal JJ; Holtzman SG
    Eur J Pharmacol; 1980 Nov; 68(1):1-10. PubMed ID: 6256182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
    Picker M; Dykstra LA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.
    Snell D; Harris RA
    Psychopharmacology (Berl); 1982; 76(2):177-81. PubMed ID: 6281840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.